Drug Shortage Report for TOBRAMYCIN FOR INJECTION USP
Report ID | 39011 |
Drug Identification Number | 02285150 |
Brand name | TOBRAMYCIN FOR INJECTION U.S.P. |
Common or Proper name | TOBRAMYCIN FOR INJECTION U.S.P. |
Company Name | STERIMAX INC |
Market Status | DORMANT |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 1.2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 6 VIALS |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-02-05 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-03-29 |
Company comments | Manufacturer changes |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-03-29 | French | Compare |
v7 | 2019-03-29 | English | Compare |
v6 | 2019-03-29 | English | Compare |
v5 | 2018-03-20 | French | Compare |
v4 | 2018-03-20 | English | Compare |
v3 | 2018-02-07 | French | Compare |
v2 | 2018-02-07 | English | Compare |
v1 | 2018-02-07 | English | Compare |
Showing 1 to 8 of 8